It is an undeniable fact in the scientific community that the research and discoveries of Katalin Karikó, a Hungarian-born scientist and current senior vice president at BioNTech, were a significant ...
mRNA, widely known from the COVID-19 vaccine, is not actually a “therapeutic agent,” but a technology that delivers the blueprint for functional proteins into the body so that induces therapeutic ...
新型コロナ感染症 ファイザー、ワクチン最終分析で有効性95%と発表(写真:ロイター/アフロ) [ロンドン発]米製薬大手 ...
Katalin Kariko, speaks after receiving, together with six other scientists, the Princess of Asturias Award for Technical & Scientific Research 2021 from Spain's Princess of Asturias Leonor, at a ...
Vaccines that resemble viruses generally produce a stronger immune response, while mRNA versions are much quicker and cheaper to make. Now we are getting the best of both worlds, in the form of mRNA ...
Researchers say the COVID-19 pandemic has provided an opportunity to boost a technology that may hold great promise for a new era of medicine. Watch the webinar mRNA technology has become a hot topic ...
The mRNA technology from COVID-19 vaccines may help amplify cancer treatments that use the body’s own immune system to fight cancer, a new study has found. Cancer patients who received an mRNA-based ...
Cancer patients who received the mRNA-based jab after starting immunotherapy lived significantly longer than those who did not get the vaccine. The mRNA technology from COVID-19 vaccines may help ...
In a Phase 3 trial of more than 18,000 volunteers across three countries, an mRNA influenza vaccine from Pfizer has outperformed standard seasonal flu shots by 34.5%. It's yet another sign that this ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する